VOYA Investment Management
PLRX icon

VOYA Investment Management’s Pliant Therapeutics PLRX Stock Holding History

VOYA Investment Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,319
Closed -$22K – 2726
2025
Q1 		$22K Sell
16,319
-18,504
-53% -$112K ﹤0.01% 2615
2024
Q4 		$459K Sell
34,823
-1,615
-4% -$22.1K ﹤0.01% 1980
2024
Q3 		$408K Sell
36,438
-292
-0.8% -$3.65K ﹤0.01% 2112
2024
Q2 		$395K Sell
36,730
-1,961
-5% -$25.3K ﹤0.01% 2122
2024
Q1 		$576K Sell
38,691
-3,627
-9% -$59.8K ﹤0.01% 1948
2023
Q4 		$766K Buy
42,318
+250
+0.6% +$3.8K ﹤0.01% 1837
2023
Q3 		$729K Buy
42,068
+331
+0.8% +$5.74K ﹤0.01% 1837
2023
Q2 		$756K Buy
41,737
+3,592
+9% +$85K ﹤0.01% 1847
2023
Q1 		$1.01M Buy
+38,145
New +$1.09M ﹤0.01% 1649
2021
Q3 		– Sell
-9,905
Closed -$288K – 2830
2021
Q2 		$288K Sell
9,905
-433
-4% -$13.5K ﹤0.01% 2394
2021
Q1 		$407K Buy
+10,338
New +$336K ﹤0.01% 2148

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

VOYA Investment Management's PLRX Position: Q2 2025 in Review

VOYA Investment Management sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 16,319 shares — an estimated $22K sold.

VOYA Investment Management first reported a position in PLRX in Q1 2021 and held it in 11 quarters. The position peaked at $1.01M in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • VOYA Investment Management reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 16,319 Pliant Therapeutics shares in Q2 2025, an estimated $22K.
  • VOYA Investment Management first reported a position in Pliant Therapeutics in Q1 2021 and held it in 11 quarters.
  • VOYA Investment Management's Pliant Therapeutics position peaked at $1.01M in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.